Patient-reported benefits from nabiximols treatment in multiple sclerosis-related spasticity exceed conventional measures
{{output}}
Aim: This prospective, multicenter, open-label, noninterventional 12-week study investigated the effectiveness and tolerability of add-on nabiximols oromucosal spray (Sativex®) in the real-world setting in Germany. Patients & methods: The main analysis set co... ...
